Epigral Limited
NSE EPIGRAL.NS
Epigral Limited EBITDA for the year ending March 31, 2024: USD 57.15 M
-
Epigral Limited EBITDA for the year ending March 31, 2023 was USD 84.94 M, a 24.70% change year over year.
-
Epigral Limited EBITDA for the year ending March 31, 2022 was USD 68.11 M, a 87.84% change year over year.
-
Epigral Limited EBITDA for the year ending March 31, 2021 was USD 36.26 M, a 38.86% change year over year.
-
Epigral Limited EBITDA for the year ending March 31, 2020 was USD 26.11 M, a -42.06% change year over year.
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
| CEO | Mr. Kaushal Ashisbhai Soparkar |
| IPO Date | Aug. 31, 2023 |
| Location | India |
| Headquarters | Epigral Tower |
| Employees | 997 |
| Sector | Industrials |
| Industries | |
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products. The company serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.
Past 5 years
StockViz Staff
January 16, 2025
Any question? Send us an email